health
PPARδ activation strengthens T cells against resistant tumours in mice
A preclinical study found that activating PPARδ in immune cells improved tumour control and checkpoint therapy responses in mouse models of immune-evasive colorectal cancer. Experiments with human cells and tumour organoids also showed stronger anti-tumour activity.